Peers of Unicycive Therapeutics Inc (UNCY)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
56.27x
As of Mar 28, 2024
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Mar 28, 2024 | 56.27x |
| Mar 27, 2024 | 60.36x |
| Mar 26, 2024 | 59.85x |
| Mar 25, 2024 | 63.42x |
| Mar 22, 2024 | 60.87x |
| Mar 21, 2024 | 53.71x |
| Mar 20, 2024 | 58.31x |
| Mar 19, 2024 | 56.78x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison